Inactive Instrument

Nvest Inc. Stock Other OTC

MJVP

US67075X1063

NutraProducts Inc. is a contract manufacturer specializing in the production of gummy supplements that are vegan, and free from allergens and gluten. The Company also offers comprehensive services, including product development, packaging, labeling, and third-party logistics (3PL). Utilizing starch-less mold technology, the Company ensures a contaminant-free environment, delivering products that meet stringent quality standards. Its products include Gummies, Drinks, and Bulk Ingredients. Its ready-to-drink, private-labeled formulations are shelf-stable, customizable, and designed for maximum flavor and function. It also offers a wide range of bulk ingredients, including functional compounds and custom blends, ready for use. Its Gummies are custom formulated with precise dosing and clean ingredients.

Employees

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	592K 512K 478K 439K 826K 56.36M 838K 5.61M 2.2M 28.23M 2.22M 2.17M 93.48M	P/E 2014	-13.1x	P/E 2015	-11.3x
Enterprise Value	547K 473K 442K 405K 763K 52.06M 774K 5.18M 2.03M 26.08M 2.05M 2.01M 86.35M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.61%	Yield 2014 *	-	Yield 2015	-

18/05/18	MJ Venture Partners, Inc. Appoints Brett H. Pojunis as Chairman and Chief Executive Officer	CI
10/04/18	GoTraq Inc. will Change its Name to MJ Venture Partners, Inc	CI
10/04/18	MJ Venture Partners, Inc. has Changed its Ticker to MJVP from GTRQ	CI
13/11/15	Traack Technologies Inc. Auditor Raises 'Going Concern' Doubt	CI
25/08/15	GeoTraq, Inc. Launches Cell-ID Device Management Platform	CI
11/08/15	GeoTraq Seeks Acquisitions	CI
11/08/15	GeoTraq Inc. terminated the acquisition of Ci2i Services, Inc. and OmniM2M LLC.	CI
05/08/15	GeoTraq Announces Successful Testing of the G-200 Cell-ID Module in Both Lab and Real World Testing	CI
28/07/15	GeoTraq Inc. entered into a letter of intent to acquire Ci2i Services, Inc. and OmniM2M LLC for $10.8 million.	CI
02/06/15	GeoTraq Inc. Files Patent Application for First Cell-ID Module	CI
01/01/15	GeoTraq Inc. Announces Management Changes	CI
23/12/14	GeoTraq Inc. Creates Cell-ID Transceiver Module	CI
09/04/14	GeoTraq Inc. Appoints Gregg Sullivan as President, Chief Executive Officer, Chief Financial Officer and Director	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NVEST INC.	+2.14%	-.--%	-	-	7.2M
ELI LILLY AND COMPANY	-0.52%	+3.21%	+89.52%	+127.32%	1,057B
JOHNSON & JOHNSON	+0.88%	+1.13%	+49.56%	+49.69%	625B
ABBVIE INC.	+0.89%	-1.95%	+24.23%	+64.44%	435B
ROCHE HOLDING AG	+0.71%	+3.87%	+49.07%	+37.85%	363B
NOVARTIS AG	+0.64%	-0.49%	+33.94%	+40.01%	296B
ASTRAZENECA PLC	+0.39%	-5.83%	+8.92%	+7.85%	249B
AMGEN INC.	+1.51%	+6.69%	+42.58%	+57.57%	222B
NOVO NORDISK A/S	+3.92%	-0.46%	-5.56%	-52.32%	209B
GILEAD SCIENCES, INC.	+1.80%	+2.30%	+11.56%	+66.35%	165B
Average	+1.24%	+0.87%	+33.76%	+44.31%	402.31B
Weighted average by Cap.	+0.66%	+1.22%	+48.72%	+64.63%

	2014	2015
Net sales	-	-
Net income	-311K -269K -251K -231K -434K -29.61M -440K -2.95M -1.16M -14.83M -1.17M -1.14M -49.11M	-506K -438K -409K -375K -706K -48.2M -717K -4.8M -1.88M -24.14M -1.9M -1.86M -79.95M
Net Debt	397K 343K 321K 294K 553K 37.78M 562K 3.76M 1.47M 18.92M 1.49M 1.46M 62.66M	-45.13K -39.05K -36.47K -33.45K -62.94K -4.3M -63.87K -428K -168K -2.15M -169K -166K -7.13M

Nvest Inc. Stock Other OTC

Stocks

MJVP

US67075X1063

Pharmaceuticals

Valuation: Nvest Inc.

Latest news : Nvest Inc.

Quotes and Performance

Managers and Directors: Nvest Inc.

Other Pharmaceuticals

Financials

Company Profile